XJPX7062
Market cap16mUSD
Dec 27, Last price
1,081.00JPY
1D
2.46%
1Q
-31.41%
IPO
-69.11%
Name
Fureasu Co Ltd
Chart & Performance
P/E
43.62
P/S
0.45
EPS
24.78
Div Yield, %
0.98%
Shrs. gr., 5y
—
Rev. gr., 5y
8.11%
Revenues
5.71b
+24.56%
Net income
58m
+84.59%
CFO
172m
P
Dividend
Mar 28, 20250 JPY/sh
Profile
Fureasu Co.,Ltd. engages in the massage, massage franchise, and other businesses in Japan. It offers various massage services, including home acupuncture, moxibustion massage, office massage, and support for the visually impaired; small-scale multi-functional in-home nursing care, home-visit care, commuting, and overnight stays; home-visit nursing services; medical care facilities; and home care services, which include eating, excretion, and bathing. Fureasu Co.,Ltd. was founded in 2000 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | |||||
Revenues | 5,710,030 24.56% | 4,584,081 9.81% | 4,174,557 13.68% | ||
Cost of revenue | 3,015,252 | 2,346,064 | 2,095,714 | ||
Unusual Expense (Income) | |||||
NOPBT | 2,694,778 | 2,238,017 | 2,078,843 | ||
NOPBT Margin | 47.19% | 48.82% | 49.80% | ||
Operating Taxes | 65,271 | 58,003 | 110,579 | ||
Tax Rate | 2.42% | 2.59% | 5.32% | ||
NOPAT | 2,629,507 | 2,180,014 | 1,968,264 | ||
Net income | 58,305 84.59% | 31,586 -78.64% | 147,853 149.25% | ||
Dividends | (24,810) | (21,733) | |||
Dividend yield | 1.08% | 1.03% | |||
Proceeds from repurchase of equity | 7,596 | 2,990 | |||
BB yield | -0.36% | -0.14% | |||
| Debt | |||||
Debt current | 828,265 | 423,722 | 392,854 | ||
Long-term debt | 4,380,945 | 2,223,436 | 602,497 | ||
Deferred revenue | 30,657 | 26,425 | |||
Other long-term liabilities | 219,447 | 158,956 | 122,210 | ||
Net debt | 3,846,395 | 1,504,895 | (282,170) | ||
| Cash flow | |||||
Cash from operating activities | 172,023 | (233,145) | 309,270 | ||
CAPEX | (125,000) | (83,932) | (142,891) | ||
Cash from investing activities | (193,600) | (516,914) | (149,467) | ||
Cash from financing activities | 177,128 | 511,112 | (160,972) | ||
FCF | 1,251,171 | 1,286,266 | 1,925,902 | ||
| Balance | |||||
Cash | 1,130,815 | 975,263 | 1,214,521 | ||
Long term investments | 232,000 | 167,000 | 63,000 | ||
Excess cash | 1,077,314 | 913,059 | 1,068,793 | ||
Stockholders' equity | 1,471,761 | 1,441,322 | 1,438,635 | ||
Invested Capital | 4,393,082 | 3,070,956 | 1,682,617 | ||
ROIC | 70.46% | 91.72% | 116.08% | ||
ROCE | 48.61% | 55.05% | 73.18% | ||
| EV | |||||
Common stock shares outstanding | 2,375 | 2,368 | 2,370 | ||
Price | 967.00 8.53% | 891.00 -2.30% | 912.00 -17.84% | ||
Market cap | 2,296,919 8.88% | 2,109,680 -2.39% | 2,161,275 -17.45% | ||
EV | 6,143,314 | 3,614,575 | 1,879,105 | ||
EBITDA | 2,851,617 | 2,335,391 | 2,146,346 | ||
EV/EBITDA | 2.15 | 1.55 | 0.88 | ||
Interest | 38,930 | 13,550 | 6,535 | ||
Interest/NOPBT | 1.44% | 0.61% | 0.31% | ||